The generated survival curves did not show a clear separation especially between AML with mutated NPM1, AML with myelodysplasia-related gene mutations, and AML with myelodysplasia-related cytogenetic abnormalities (Fig. 4C). This evidence concerns the gene NPM1 and acute myeloid leukemia.